Atlas Trials

Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment

Clinical trial NCT06850506 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06850506
Sponsor
Peking University People's Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
SarcomaSarcoma, BoneEwing SarcomaOsteosarcoma
Start date
2024-09-01
Primary completion
2025-09-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.